Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,714 public trials 871 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Active, Not Recruiting

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

NCT05639114

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Llc Anniston, Alabama, United States
  • Providence Medical Center Burbank, California, United States
  • University of California San Diego La Jolla, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

NCT06331312

Conditions
Connective Tissue Diseases, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Arizona Arthritis and Rheumatology Associates PLLC Avondale, Arizona, United States
  • Sun Valley Arthritis Center Ltd Peoria, Arizona, United States
  • Center for Rheumatology Research West Hills, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 86 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

NCT05624749

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California LA Los Angeles, California, United States
  • Homestead Assoc In Research Inc Homestead, Florida, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

NCT05798117

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Pessac, France
  • Novartis Investigative Site Strasbourg, France
View Trial Details
Active, Not Recruiting

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT05925803

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Chula Vista, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT06799520

Conditions
Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
Locations
  • Visterra Investigational Site Sofia, Bulgaria
  • Visterra Investigational Site Chisinau, Moldova
  • Visterra Investigational Site Bucharest, Romania
  • Visterra Investigational Site Cluj-Napoca, Romania
View Trial Details
Active, Not Recruiting

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD

NCT05936970

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Arizona Arthritis & Rheumatology Research Phoenix, Arizona, United States
  • Medvin Clinical Research - Apple Valley Apple Valley, California, United States
  • Medvin Clinical Research - Covina Covina, California, United States
  • Medvin Clinical Research - Riverside Riverside, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

NCT04221477

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Medical Center Birmingham, Alabama, United States
  • Wallace Rheumatic Study Center Beverly Hills, California, United States
  • Kaiser Permanente - Fontana Fontana, California, United States
  • Kaiser Permanente - San Francisco Medical Center San Francisco, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

NCT05540327

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Bay Area Arthritis and Osteoporosis Brandon, Florida, United States
  • Advance Medical Research Center Miami, Florida, United States
  • Dawes Fretzin Dermatology Group, LLC Indianapolis, Indiana, United States
View all 122 locations
View Trial Details
Active, Not Recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT06843239

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 60 locations
View Trial Details

Related conditions